methylprednisolone has been researched along with Ambulation Disorders, Neurologic in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, ZK; Kong, FX; Lu, QH | 1 |
| Afshari, K; Alesaeidi, S; Heidary, M | 1 |
| Badner, A; Fehlings, MG; Hong, J; Ulndreaj, A; Vidal, PM | 1 |
| Ceanga, M; Chung, HY; Geis, C; Sell, J; Voss, A; Wickel, J; Witte, OW | 1 |
| Araki, N; Hiraga, A; Kuwabara, S; Oikawa, M; Ozaki, D | 1 |
| Barbosa, A; Canneti, B; Carreras, T; Gilo, F; Meca-Lallana, V; Mosqueira, AJ; Vivancos, J | 1 |
| Dhurandhar, A; Fountain, EM | 1 |
| Kohli, M; Milone, M; Thanarajasingam, G | 1 |
| Baranano, KW; Klein, JL; Pardo, CA; Sun, LR; Yeshokumar, AK | 1 |
| Hou, X; Lin, W; Liu, J; Ma, D; Wang, X; Xie, B; Zhang, HL | 1 |
| Amini, M; Ganji, MR; Hakemi, MS; Najafi, I; Nouri, M | 1 |
| Agaoglu, J; Icen, M; Kale, N; Tanik, O; Yazici, I | 1 |
| Cabrita, AM; Costa, LM; Couto, PA; Di Scipio, F; Filipe, VM; Fornaro, M; Geuna, S; Magalhães, LG; Maurício, AC; Pereira, JE; Varejão, AS | 1 |
| Asghar, SJ; Glasier, C; Kaushik, C; Milesi-Hallé, A; Sharp, GB | 1 |
| Buoni, S; Fois, A; Sorrentino, L; Zannolli, R | 1 |
| Hoppe, B; Stefanelli, M; Woolridge, D | 1 |
| Ajlani, H; Meddeb, N; Mrabet, D; Sahli, H; Sellami, S | 1 |
| Burkhard, PR; Kaiser, L; Lalive, PH; Landis, T; Perrin, L; Pot, C; Villard, J | 1 |
| Azbill, RD; Mu, X; Springer, JE | 1 |
1 review(s) available for methylprednisolone and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Horizontal eyeball akinesia as an initial manifestation of CLIPPERS: Case report and review of literature.
Topics: Anti-Inflammatory Agents; Azathioprine; Central Nervous System Diseases; Diagnosis, Differential; Dizziness; Female; Gait Disorders, Neurologic; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Ocular Motility Disorders; Pons | 2016 |
18 other study(ies) available for methylprednisolone and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Multiple intracranial lesions as the unusual imaging features of Hashimoto's encephalopathy: A case report.
Topics: Administration, Intravenous; Autoantibodies; Brain Diseases; Cognitive Dysfunction; Dizziness; Electroencephalography; Encephalitis; Female; Gait Disorders, Neurologic; Glucocorticoids; Hashimoto Disease; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Cerebellar degeneration in primary Sjӧgren syndrome.
Topics: Autoantibodies; Cyclophosphamide; Female; Gait Disorders, Neurologic; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuroprotective Agents; Sjogren's Syndrome; Spinocerebellar Degenerations; Treatment Outcome; Young Adult | 2018 |
Methylprednisolone treatment enhances early recovery following surgical decompression for degenerative cervical myelopathy without compromise to the systemic immune system.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Blood Cells; Cytokines; Decompression, Surgical; Disease Models, Animal; Female; Flow Cytometry; Gait Disorders, Neurologic; Laser-Doppler Flowmetry; Leukocytes; Methylprednisolone; Mice; Mice, Inbred C57BL; Neuroglia; Recovery of Function; Spinal Cord; Spinal Cord Compression; Time Factors | 2018 |
Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: A case report.
Topics: Administration, Intravenous; Autoantibodies; Cell Adhesion Molecules, Neuronal; Cognitive Dysfunction; Cyclophosphamide; Depressive Disorder; Dysarthria; Encephalitis; GABA-B Receptor Antagonists; Gait Disorders, Neurologic; Glucocorticoids; Hallucinations; Hashimoto Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Plasmapheresis; Sleep Wake Disorders; Treatment Outcome | 2019 |
Recurrent Neurological Episodes for 10 Years Preceding Skin Lesions in Neuro-Sweet Disease.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Dapsone; Diagnosis, Differential; Diplopia; Drug Administration Schedule; Drug Therapy, Combination; Gait Disorders, Neurologic; Humans; Infusions, Intravenous; Male; Meningoencephalitis; Methylprednisolone; Nervous System Diseases; Nystagmus, Pathologic; Prednisolone; Recurrence; Seizures; Skin Diseases; Sweet Syndrome | 2019 |
[CLIPPERS syndrome with atypical distribution of lesions in magnetic resonance imaging of the brain].
Topics: Adult; Anti-Inflammatory Agents; Brain; Cerebellum; Diplopia; Dysarthria; Encephalitis; Female; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Methylprednisolone; Neuroimaging; Pons; Recurrence; Syndrome | 2013 |
Neuro-Behçet's disease: an unusual cause of headache.
Topics: Anti-Inflammatory Agents; Behcet Syndrome; Diagnosis, Differential; Female; Gait Disorders, Neurologic; Headache; Humans; Ibuprofen; Meningitis, Aseptic; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neoplasms; Neuroimaging; Neurologic Examination; Treatment Outcome | 2014 |
Paraneoplastic encephalopathy: an unusual presenting feature of bladder cancer metastasis.
Topics: Aged; Brain Diseases; Carcinoma, Transitional Cell; Cognition Disorders; Diagnosis, Differential; Electroencephalography; Female; Gait Disorders, Neurologic; Humans; Methylprednisolone; Neoplasm Recurrence, Local; Neuroprotective Agents; Paraneoplastic Syndromes, Nervous System; Pelvis; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms | 2015 |
Gait Disturbance as the Presenting Symptom in Young Children With Anti-NMDA Receptor Encephalitis.
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antibodies; Brain; Child, Preschool; Dyskinesias; Female; Gait Disorders, Neurologic; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant; Magnetic Resonance Imaging; Male; Methylprednisolone; Receptors, N-Methyl-D-Aspartate; Seizures; Sleep Initiation and Maintenance Disorders; Speech Disorders | 2016 |
Foot-drop: an unusual complaint in Henoch-Schönlein purpura.
Topics: Administration, Oral; Adolescent; Cyclophosphamide; Dose-Response Relationship, Drug; Gait Disorders, Neurologic; Glucocorticoids; Humans; IgA Vasculitis; Immunosuppressive Agents; Injections, Intravenous; Male; Mercaptopurine; Methylprednisolone; Prednisolone; Recovery of Function | 2009 |
Clustering of organ-specific autoimmunity: a case presentation of multiple sclerosis and connective tissue disorders.
Topics: Activities of Daily Living; Autoimmune Diseases; Autoimmunity; Brain; Cluster Analysis; Connective Tissue Diseases; Disease Progression; Familial Mediterranean Fever; Gait Disorders, Neurologic; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Paraparesis; Spondylitis, Ankylosing; Treatment Failure | 2008 |
Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats.
Topics: Animals; Biomechanical Phenomena; Disability Evaluation; Disease Models, Animal; Female; Gait Disorders, Neurologic; Glucocorticoids; Methylprednisolone; Neurologic Examination; Paraplegia; Rats; Rats, Wistar; Recovery of Function; Severity of Illness Index; Spinal Cord; Spinal Cord Injuries | 2009 |
Variable manifestations of familial hemiplegic migraine associated with reversible cerebral edema in children.
Topics: Adolescent; Anti-Inflammatory Agents; Brain Edema; Calcium Channel Blockers; Calcium Channels; Child; Cognition Disorders; DNA; Electroencephalography; Female; Functional Laterality; Gait Disorders, Neurologic; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methylprednisolone; Migraine with Aura; Neurologic Examination; Sodium-Potassium-Exchanging ATPase; Verapamil | 2012 |
Betamethasone and improvement of neurological symptoms in ataxia-telangiectasia.
Topics: Ataxia; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Betamethasone; Cell Cycle Proteins; Cerebellum; Child, Preschool; Conjunctiva; DNA-Binding Proteins; Drug Administration Schedule; Drug Therapy, Combination; Gait Disorders, Neurologic; Glucocorticoids; Humans; Male; Methylprednisolone; Protein Serine-Threonine Kinases; Recovery of Function; Treatment Outcome; Tumor Suppressor Proteins | 2006 |
Susac syndrome with frontal intermittent rhythmic delta activity (FIRDA).
Topics: Adult; Brain Diseases; Calcium Channel Blockers; Delta Rhythm; Gait Disorders, Neurologic; Hearing Loss; Humans; Lysine; Magnetic Resonance Imaging; Male; Methylprednisolone; Neuroprotective Agents; Nimodipine; Retinal Artery Occlusion; Vision Disorders | 2006 |
Cerebral vasculitis in a patient with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Drug Therapy, Combination; Female; Gait Disorders, Neurologic; Glucocorticoids; Headache; Humans; Magnetic Resonance Angiography; Methylprednisolone; Middle Aged; Treatment Outcome; Vasculitis, Central Nervous System | 2007 |
Human herpesvirus-6 variant A encephalomyelitis.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Central Nervous System; Cerebellum; Disease Progression; Encephalomyelitis; Female; Fever; Gait Disorders, Neurologic; Ganciclovir; Herpesvirus 6, Human; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Neural Pathways; Roseolovirus Infections; Somatosensory Disorders; Spinal Cord; Treatment Outcome | 2008 |
Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury.
Topics: Animals; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Gait Disorders, Neurologic; Glucocorticoids; Glutamic Acid; Locomotion; Methylprednisolone; Myelin Sheath; Rats; Rats, Long-Evans; Recovery of Function; Riluzole; Spinal Cord; Spinal Cord Injuries | 2000 |